In molecular profiling studies of cancer patients, experimental and clinical data are combined in order to understand the clinical heterogeneity of the disease: clinical information for each subject needs to be linked to tumour samples, macromolecules extracted, and experimental results.
These procedures require large amounts of protein extract and stringent experimental conditions, while many techniques have also been deemed best suited for situations where a high affinity ligand binds to a protein [1, 9].
The range of concentration of L.obtusiloba extract and the experimental protocols were adapted from preceding studies dealing with the extract [ 31, 32].
This was a ten-day bioassay with a completely randomized design, in which the treatments consisted of different concentrations of Yucca extract and the experimental units were the gerbil groups infected with 5 × 10 trophozoites of the G. intestinalis clone GS/M-83-H7.
Based on expert surveys, the concept of Kansei Engineering is used to extract and evaluate the experimental samples, and a morphological analysis is used to extract form elements from these sample mobile phones.
All experimental extract and standard medicine were administered orally.
The experimental extract and acarbose were tested with varying concentrations from 1.25 to 5 mg/ml.
It is unclear how much myosin is really depleted using this method, other myosins are likely to be present in the extract, and there is no experimental evidence that myosin really localizes to the cortex in this system.
Thus, methods to extract and analyze kinetic information from experimental studies provide an important step in the development of the subject.
MK: performed the study as his PhD work; MKG: literature search, data acquisition, data analysis and prepared the manuscript; AS: helped in the preparation of the extracts and experimental studies; RKG: supervised and evaluated the data and review the manuscript for publication.
